Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 183 participants.
Also called NCT01047566
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 183 participants
- Sponsor
- Registry
-
NCT01047566 -
2009-018215-53
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01047566. Randomized; no masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2011-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)
- Acronym
- AFRODITE
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Dronedarone
- Intervention (Drug)
- Beta blocker or calcium antagonist or digoxin
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01047566- Content hash
941d9c1960f31f5e5bc85b22b82c3a0aef18d6cb9a44ac7e6d34649607f94b33